A new Zika virus medicine has been given the go-ahead to be tested on humans The vaccine’s creators Inovio Pharmaceuticals and GeneOne Life Science announced Monday that the group was given permission from the U.S. health regulators to start an early-stage trial The companies plan to enroll 40 healthy people to test the vaccine’s safety and immune response